Synlogic (United States)

Institution (Company)

Homepage ROR

Also Known As

Synlogic (United States)

Publications

32.6K

Citations

Authors

Concepts

About

Synlogic (United States) is a company institution in Cambridge, United States known for medicine, engineering, and synthetic biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	56	6.1K
2	Engineering	5	44	11.4K
3	Health Sciences	1	1	63
4	Natural Sciences	1	1	23
5	Public Health	1	13	351

Synlogic (United States)

Publications

32.6K

Citations

Page 1

	Year	Citations
Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria Vincent M. Isabella, Binh Ha, Mary Joan Castillo, Nature Biotechnology BiosynthesisEngineeringBiotechnologySynthetic BiologyMicrobiology	2018	548
Metabolic modulation of tumours with engineered bacteria for immunotherapy Fernando P. Canale, Camilla Basso, Gaia Antonini, Nature Cancer ImmunosurveillanceEngineered BacteriaMedicineImmunologySynthetic Biology	2021	541
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity Daniel S. Leventhal, Anna Sokolovska, Ning Li, Nature Communications	2020	410
An engineered <i>E. coli</i> Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans Caroline Kurtz, Yves Millet, Marja Puurunen, Science Translational Medicine	2019	366
Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation Jamie Bates, Archana Vijayakumar, Sarani Ghoshal, Journal of Hepatology	2020	215
The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls Jonna Jalanka, Giles Major, Kathryn Murray, International Journal of Molecular Sciences	2019	198
Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study Marja Puurunen, Jerry Vockley, Shawn Searle, Nature Metabolism EngineeringMedicineFirst-in-human Phase 1/2ABiotechnologySynthetic Biology	2021	146
Lactate limits CNS autoimmunity by stabilizing HIF-1α in dendritic cells Liliana M. Sanmarco, Joseph M. Rone, Carolina Manganeli Polonio, Nature	2023	144
Deregulation of S-adenosylmethionine biosynthesis and regeneration improves methylation in the E. coli de novo vanillin biosynthesis pathway Aditya M. Kunjapur, Jason C. Hyun, Kristala L. J. Prather Microbial Cell Factories	2016	112
Improvement of a synthetic live bacterial therapeutic for phenylketonuria with biosensor-enabled enzyme engineering Kristin J. Adolfsen, Isolde Callihan, Catherine Monahan, Nature Communications	2021	91

Page 1